Asparagus adscendens (Shweta musali) stimulates insulin secretion, insulin action and inhibits starch digestion

British Journal of Nutrition

Volumn 95, Issue 3, 2006, Pages 576-581

  Mathews, Jacqueline N ^a   Flatt, Peter R ^a   Abdel Wahab, Yasser H ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Asparagus adscendens; Diabetes; Insulin

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; ASPARAGUS ADSCENDENS EXTRACT; DIAZOXIDE; INSULIN; ISOBUTYLMETHYLXANTHINE; METFORMIN; MOLYBDIC ACID; ORTHOVANADIC ACID; PLANT EXTRACT; POTASSIUM CHLORIDE; STARCH; TOLBUTAMIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ADIPOCYTE; ANIMAL CELL; ARTICLE; ASPARAGUS; ASPARAGUS ADSCENDENS; CELL LINE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; IN VITRO STUDY; INCIDENCE; INSULIN LIKE ACTIVITY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; STATISTICAL ANALYSIS;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ASPARAGUS PLANT; CALCIUM; CELL LINE; DIGESTION; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MEMBRANE POTENTIALS; MICE; PLANT EXTRACTS; RATS; STARCH;

ANIMALIA; ASPARAGUS; EMBRYOPHYTA;

EID: 33645537215     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20051650     Document Type: Article

References (29)

1. Amos AF, McCarty DJ & Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14, S1-S85.
2. Astin JA (1998) Why patients use alternative medicine. Results of a national study. JAMA 279, 1548-1553.
3. Bailey CJ & Day C (1989) Traditional treatments for diabetes. Diabetes Care 12, 553-564.
4. Brevoort P (1998) The booming US botanical market - new overview. Herbalgram 44, 33-46.
5. Clark CJ (1998) The burden of chronic hyperglycaemia. Diabetes Care 21, C32-C34.
6. Day C (1990) Hypoglycaemic compounds from plants. In New AntiDiabetic Drugs, pp. 267-278 [CJ Bailey and PR Flatt, editors]. London: Smith-Gordon.
7. De Fronzo RA, Banadonna RC & Ferrannini E (1992) Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15, 318-368.
8. Dunn CJ & Peters DH (1995) Metformin: a review of its pharmacological properties and therapeutic use in NIDDM. Drugs 49, 721-749.
9. Flatt PR & Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 20, 573-577.
10. Foyt HL, Ghazzi MN, Hanley RM, Saltiel AR & Whitcomb RW (2000) Thiazolidinediones. In Diabetes Mellitus. A Fundamental and Clinical Text, pp. 788-797 [D Le Roith, SI Taylor and JM Olefsky, editors]. Philadelphia: Lippincott, Williams and Wilkins.
11. Frost SC & Lane MD (1985) Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem 260, 2646-2652.
12. Gray AM & Flatt PR (1997) Nature's own pharmacy: the diabetes perspective. Proc Nutr Soc 56, 507-517.
13. Hunt SM, Chrzanowska C, Barnett CR, Brand HN & Fawell JK (1987) A comparison of in vitro cytotoxicity assays and their application to water samples. Altern Lab Anim 15, 20-29.
14. Kawabata J, Mizuhatak, Sato E, Nishioka T, Aoyana Y & Kasai T (2003) 6-Hydroxyflavonoids as alpha-glucosidase inhibitors from majoram (Origanum majorana) leaves. Biosci Biotechnol Biochem 67, 445-447.
15. Kurihara H, Fukami H, Kusumoto A, Toyoda Y, Shibata H, Matsui Y, Asami S & Tanaka T (2003) Hypoglycaemic action of Cyclocarya paliurus (Batal) Iljinskaja in normal and diabetic mice. Biosci Biotechnol Biochem 67, 877-880.
16. Laws A (2001) A new era in type 2 diabetes mellitus treatment? Am J Med 111, 71-72.
17. Lilloja S, Mott DM, Spraul M, Ferraro R, Foley JE & Ravussin E (1993) Insulin resistance and insulin secretory dysfunction as precursor of non-insulin dependent diabetes mellitus. N Engl J Med 329, 1988-1992.
18. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YHA, O'Harte FPM, Yoon TW, Swanston-Flatt SK & Flatt PR (1996) Characterisation of a novel glucose responsive insulin secreting cell line, BRIN BD11, produced by electrofusion. Diabetes 45, 1132-1140.
19. MacLennan AH, Wilson DH & Taylor AW (1996) Prevalence and cost of alternative medicine in Australia. Lancet 347, 569-573.
20. Mandrup-Poulsen T (1998) Effect of a high monounsaturated fat diet rich in avocado in NIDDM patients. Diabetes Care 4, 311-315.
21. Miguel JC, Abdel-Wahab YHA, Mathias PC & Flatt PR (2003) Time-correlation between membrane depolarisation and intracellular calcium in insulin secreting BRIN-BD11 cells: studies using FLIPR. Cell Calcium 36, 43-50.
22. Oubre AY, Carlson TJ, King SR & Reavan GM (1997) From plant to patient: an ethnobotanical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia 40, 614-617.
23. Rhinehart BL, Robinson KM, Payne AJ, Wheatley ME, Fisher JL, Liu PS & Cheung W (1987) Castanospermine blocks the hyperglycaemic response to carbohydrates in vivo: a result of intestinal disaccharidase inhibition. Life Sci 41, 2325-2331.
24. Shinwari IM & Khan AM (2000) Folk use of medicinal herbs of Margalla Hills National Park, Islamabad. J Ethnopharmacol 69, 45-56.
25. Swanston-Flatt SK, Day C, Flatt PR & Bailey CJ (1991a) Evaluation of the antihyperglycaemic properties of traditional plant treatments for diabetes. In Frontiers in Diabetes Research: Lessons from Animal Diabetes, Vol. 3, pp. 286-293 [E Shafrir, editor]. London: Smith-Gordon and Company.
26. Swanston-Flatt SK, Flatt PR, Day C & Bailey CJ (1991b) Traditional dietary adjuncts for the treatment of diabetes mellitus. Proc Nutr Soc 50, 641-651.
27. UKPDS (1995) Perspectives in diabetes. UKPDS Study 16. Overview of 6 years therapy of type II diabetes: a progressive disease. Diabetes 44, 1249-1258.
28. Weragoda PB (1980) Some questions about the future of traditional medicine in developing countries. J Ethnopharmacol 2, 193-194.
29. Yoshikuni Y (1998) Inhibition of intestinal a-glucosidase activity in postprandial hyperglycaemia by moraline and its n-alkyl derivatives. Agric Biol Chem 52, 121-128.